Recruiting Scleroderma Studies in Dallas
About Scleroderma Clinical Trials in Dallas
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 3 scleroderma clinical trials recruiting participants in Dallas, PA. These studies are seeking a combined 610 participants. Research is being sponsored by University of Texas Southwestern Medical Center, Mediar Therapeutics, aTyr Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Dallas — FAQ
Are there scleroderma clinical trials in Dallas?
Yes, there are 3 scleroderma clinical trials currently recruiting in Dallas, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dallas?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.
Are clinical trials in Dallas free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 3 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated July 13, 2026 from ClinicalTrials.gov